Ligand validation:3FXI

DAO: LAURIC ACID

DAO is a Ligand Of Interest in 3FXI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FXI_DAO_A_1007	5%	47%	0.47	0.898	0.32	1.69	-	3	1	0	93%	0.9286
3FXI_DAO_B_1007	2%	48%	0.543	0.838	0.28	1.69	-	3	1	0	93%	0.9286
4G8A_DAO_D_204	42%	55%	0.198	0.929	0.99	0.77	1	-	0	0	93%	0.9286
2WYD_DAO_B_1552	93%	68%	0.065	0.961	0.61	0.62	-	-	0	0	100%	1
3DPR_DAO_A_290	84%	47%	0.108	0.97	0.81	1.21	1	2	0	0	100%	1
5FVN_DAO_C_420	73%	74%	0.089	0.927	0.44	0.58	-	-	0	0	93%	0.9286
1E7F_DAO_A_1004	72%	56%	0.123	0.946	0.6	1.08	-	1	1	0	100%	1
4CU4_DAO_A_1012	68%	69%	0.132	0.955	0.63	0.58	1	-	1	0	93%	0.9286

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.